Chemoradiotherapy of non-small cell lung cancer

Expert Review of Anticancer Therapy

Volumn 2, Issue 4, 2002, Pages 402-407

  Jassem, Jacek ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Chemoradiation; Chemotherapy; Combined modality treatment; Non small cell lung cancer; Radiotherapy

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DNA TOPOISOMERASE INHIBITOR; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; LOMUSTINE; METHOTREXATE; MITOMYCIN C; NAVELBINE; PACLITAXEL; TAXANE DERIVATIVE; VINBLASTINE; VINDESINE; ANTINEOPLASTIC AGENT;

ADVANCED CANCER; CANCER CONTROL; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERADICATION THERAPY; HUMAN; INOPERABLE CANCER; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; METASTASIS; MULTIMODALITY CANCER THERAPY; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PROSPECTIVE STUDY; REVIEW; THORAX; LUNG TUMOR;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS, PHASE III; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS;

EID: 0036685909     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737140.2.4.402     Document Type: Review

References (48)

1. Global cancer statistics
2. Non-small cell lung cancer. I. Biology, diagnosis and staging
3. Radiotherapy for non-small cell lung cancer
4. Induction chemotherapy with cisplatin, etoposide and vindesine before radiation chemotherapy for non-small cell lung cancer. A randomised study
5. Inoperable non-small cell lung cancer: Radiation with or without chemotherapy
6. Thoracic radiation therapy alone compared with chemoradiotherapy for locally unresectable non-small cell carcinoma of the lung
7. Combined radiotherapy and chemotherapy versus radiotherapy alone in locally advanced epidermoid bronchogenic carcinoma. A randomized study
8. A randomized clinical trial comparing radiation therapy plus cisdichlorodiammine platinum in the treatment of locally advanced non-small cell lung cancer
9. Radical radiotherapy and chemotherapy in localized inoperable non-small cell lung cancer: A randomized trial
10. A randomized study of high-dose split course radiotherapy preceded by high-dose chemotherapy versus high-dose radiotherapy only in locally advanced non-small cell lung cancer. An EORTC Lung Cancer Co-operative Group trial
11. Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small cell lung cancer
12. Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small cell lung cancer
13. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
14. Inoperable non-small cell lung cancer: Radiation with or without chemotherapy
15. Thoracic radiation therapy alone compared with chemoradiotherapy for locally unresectable non-small cell carcinoma of the lung
16. Cisplatin-based chemotherapy (CT) in patients with locally advanced non-small cell lung cancer (NSCLC): Late analysis of a French randomized trial
17. Improved survival in stage III non-small cell lung cancer: Seven-year follow-up of cancer and leukemia group B [CALGB] 8433 trial
18. Final results of Phase III trial in regionally advanced unresectable non-small cell lung cancer
19. Comparison of induction chemotherapy before radiotherapy with radiotherapy only in patients with locally advanced squamous cell carcinoma of the lung
20. Mitomycin, ifosfamide and cisplatin in unresectable non-small cell lung cancer: Effects on survival and quality of life
21. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer
22. Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer
23. A randomized Phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: Final report of an Australian multi-centre trial
24. Radiosensitization with carboplatin for patients with unresectable Stage III non-small cell lung cancer: A Phase III trial of the Cancer and Leukemia Group B and the Eastern Co-operative Oncology Group
25. A Phase III trial of thoracic irradiation with and without concomitant cisplatin fbr locally advanced unresectable non-small cell lung cancer a Hoosier Oncology Group study
26. Combined radiotherapy and chemotherapy versus radiotherapy alone in locally advanced epidermoid bronchogenic carcinoma. A randomized study
27. Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for Stage III non-small cell lung cancer
28. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for Stage III non-small cell lung cancer: A randomized study
29. Hyperfractionated radiation therapy with and without concurrent chemotherapy for advanced non-small cell lung cancer
30. Phase III study of concurrent vs. sequential thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer: Five-year median follow-up results
31. A quality-adjusted time without symptoms or toxicity (QTWiST). Analysis of Radiation Therapy Oncology Group [RTOG] 9410
32. Elderly patients (pts) with locally advanced non-small cell lung cancer (LA-NSCLC) benefit from combined modality therapy: Secondary analysis of Radiation Therapy Oncology Group (RTOG) 94-10
33. Sequential versus concurrent chemoradiation (RT-CT) in locally advanced non-small cell lung cancer (NSCLC): A French randomized Phase III trial of GLOT-GFPC (NPC 95-01 study)
34. Concurrent versus sequential radiochemotherapy with vinorelbine plus cisplatin (V-P) in locally advanced non-small cell lung cancer. A randomized Phase II study
35. Paclitaxel as a radiation sensitizer in non-small cell lung cancer
36. Docetaxel enhances tumor radioresponse in vivo
37. Concurrent conventionally fractionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small cell lung carcinoma
38. Phase II trial of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer
39. A Phase II study combining gemcitabine with radiotherapy in Stage III NSCLC
40. Gemcitabine and radiation therapy for non-small cell lung cancer
41. Vinorelbine (navelbine) in the treatment of non-small cell lung cancer: Recent developments in combination chemotherapy and radiotherapy
42. CALGB Study 9431: A randomized Phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy (Ind CT) and concomitant chemoradiotherapy (XRT) for unresectable stage III cancer (NSCLC)
43. Combined chemotherapy and radiation in locally advanced non-small cell lung cancer
44. Clinical practice guidelines for the treatment of unresectable non-small cell lung cancer
45. Radiosensitization by fluorodexouridine: Effects of thymidilate synthasae inhibition and cell synchronization
46. In vivo enhancement of tumor radioresponse by C225 anti-epidermal growth factor receptor antibody
47. Farnesyltransferase inhibitors potentiate the antitumor effect of radiation on a human xenograft expressing activated HRAS
48. Combined effect of angiostatin and ionizing radiation in antitumour therapy